24 April 2025 - It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely die from the disease, doctors say, but one of the scarce treatments available has now been made more affordable.

The Pharmaceutical Benefits Scheme approved the drug daratumumab on Thursday, providing a more affordable immunotherapy option for those ineligible for transplants or whose cancer is treatment-resistant. It is the first new treatment to be readily available for multiple myeloma in more than a decade despite progress abroad.

Read The Australian article